A Comparison of Transcranial
Magnetic Stimulation and Electroconvulsive Therapy in Non-delusional
Major Depression. A replication Study
Leon Grunhaus, Pinhas D Dannon, Shaul Schreiber
Psychiatry Division Sheba Medical Center
Increasing evidence suggests that Transcranial Magnetic Stimulation
(TMS) is an effective treatment for patients with major depression. Although
many technical issues remain unresolved studies published in recent years
support the contention that both repetitive TMS (magnetic pulses administered
at a frequency of 10Hz) over the left dorsolateral prefrontal cortex, and slow
TMS (magnetic pusles at a frequency of 1 Hz) over the right dorsolateral
prefrontal cortex are effective antidepressants. Recently, we published the
results of a comparison of rTMS and ECT in patients with major depression. The
major finding of this study was that rTMS and ECT were comparable treatments in
non-delusional major depression, while ECT was vastly superior in
delusional major depression.
To improve on our previous study we enlarged our sample of non-delusional
depressives. Ratings were performed by blind raters and patients treated with
ECT were restricted in the medications taken during the course. ECT was
performed according to established protocols. RTMS was performed over the left
dorsolateral prefrontal cortex. 1200 magnetic stimulations were administered on
a daily basis for 20 days at 90% motor threshold. All patients signed an
informed consent for participation in research.
Preliminary analysis of the data (18 patients per group) suggests that
rTMS and ECT are equally effective in this population of very sick and
medication resistant depressives. We conclude that a trial of rTMS should be
attempted in non‑delusional major depression patients before a course of
ECT is pursued.
In addition we explored the potential value of exploring cortical
excitability during rTMS. We performed cortical output maps at 120% motor
threshold (baseline, 15 and 30 minutes after the 1200 pulses) before the first
rTMS and after every fifth treatment. Preliminary analysis of the data suggests
that an exitatory response following the first treatment was associated with a
positive response to rTMS. The findings in patients will be compared with those
of normal controls.
- 31